Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06892600Completed
Randomised trial of bupivacaine (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Opioid consumption, Post-operative pain score at 24 hours and 1 more. Started Aug 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06892600.